SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
S-8 POS

Post-effective amendment to an S-8 filing

Registration Statements
View HTML
S-8 POS

Post-effective amendment to an S-8 filing

Registration Statements
View HTML
S-8 POS

Post-effective amendment to an S-8 filing

Registration Statements
View HTML
S-8 POS

Post-effective amendment to an S-8 filing

Registration Statements
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML

Data provided by Kaleidoscope.